US Patent Issued to GRETAP on Nov. 25 for "Medical treatment device and method for stimulating neurons of a patient to suppress a pathologically synchronous activity thereof" (German Inventor)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,478,783, issued on Nov. 25, was assigned to GRETAP AG (Zug, Switzerland).

"Medical treatment device and method for stimulating neurons of a patient to suppress a pathologically synchronous activity thereof" was invented by Peter Alexander Tass (Tegernsee, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention pertains to a medical treatment device for stimulating neurons of a patient to suppress a pathologically synchronous activity, the device comprises at least three non-invasive stimulating units for generating stimuli to a patient's body, and a control unit for selectively and intermittently actuating the stimulating units in a...